Bruceantin structure
|
Common Name | Bruceantin | ||
---|---|---|---|---|
CAS Number | 41451-75-6 | Molecular Weight | 548.579 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 731.0±60.0 °C at 760 mmHg | |
Molecular Formula | C28H36O11 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 239.4±26.4 °C |
Use of BruceantinBruceantin(NSC165563) is first isolated from Brucea antidysenterica, a tree used in Ethiopia for the treatment of cancer, and activity was observed against B16 melanoma, colon 38, and L1210 and P388 leukemia in mice.IC50 value:Target: anticancerCell differentiation was induced and c-MYC was down-regulated, suggesting a mechanistic correlation between c-MYC down-regulation and induction of cell differentiation or cell death. Treatment of HL-60 and RPMI 8226 cell lines induced apoptosis, and this involved the caspase and mitochondrial pathways. Moreover, an in vivo study using RPMI 8226 human-SCID xenografts demonstrated that bruceantin induced regression in early as well as advanced tumors, and these significant antitumor responses were facilitated in the absence of overt toxicity. |
Name | Bruceantin |
---|---|
Synonym | More Synonyms |
Description | Bruceantin(NSC165563) is first isolated from Brucea antidysenterica, a tree used in Ethiopia for the treatment of cancer, and activity was observed against B16 melanoma, colon 38, and L1210 and P388 leukemia in mice.IC50 value:Target: anticancerCell differentiation was induced and c-MYC was down-regulated, suggesting a mechanistic correlation between c-MYC down-regulation and induction of cell differentiation or cell death. Treatment of HL-60 and RPMI 8226 cell lines induced apoptosis, and this involved the caspase and mitochondrial pathways. Moreover, an in vivo study using RPMI 8226 human-SCID xenografts demonstrated that bruceantin induced regression in early as well as advanced tumors, and these significant antitumor responses were facilitated in the absence of overt toxicity. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 731.0±60.0 °C at 760 mmHg |
Molecular Formula | C28H36O11 |
Molecular Weight | 548.579 |
Flash Point | 239.4±26.4 °C |
Exact Mass | 548.225769 |
PSA | 165.89000 |
LogP | 2.96 |
Vapour Pressure | 0.0±5.4 mmHg at 25°C |
Index of Refraction | 1.598 |
Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
~% Bruceantin CAS#:41451-75-6 |
Literature: Hall; Lee; Okano; Sims; Ibuka; Liou; Imakura Journal of Pharmaceutical Sciences, 1981 , vol. 70, # 10 p. 1147 - 1150 |
Precursor 1 | |
---|---|
DownStream 0 |
[11b,12a,15b(E)]-15-[(3,4-Dimethyl-1-oxo-2-pentenyl)oxy]-13,20-epoxy-3,11,12-trihydroxy-2,16-dioxopicras-3-en-21-oic Acid Methyl Ester |
Methyl (11β,12α,15β)-15-{[(2E)-3,4-dimethyl-2-pentenoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate |
Methyl (11β,12α,15β)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate |
Picras-3-en-21-oic acid, 15-[[(2E)-3,4-dimethyl-1-oxo-2-penten-1-yl]oxy]-13,20-epoxy-3,11,12-trihydroxy-2,16-dioxo-, methyl ester, (11β,12α,15β)- |